SET domain containing 2 (SETD2) influences metabolism and alternative splicing during myogenesis
Open Access
- 7 July 2022
- journal article
- research article
- Published by Wiley in The FEBS Journal
- Vol. 289 (21) , 6799-6816
Abstract
Epigenetic regulatory mechanisms are increasingly recognized as crucial determinants of cellular specification and differentiation. During muscle cell differentiation (myogenesis), extensive remodelling of histone acetylation and methylation occurs. Several of these histone modifications aid in the expression of muscle‐specific genes and the silencing of genes that block lineage commitment. Therefore, the identification of new epigenetic regulatory mechanisms is of high interest. Still, the functional relevance of numerous histone modifications during myogenesis remain completely uncertain. In this study, we focus on the function of H3K36me3 and its epigenetic writer, SET domain containing 2 (SETD2), in the context of muscle cell differentiation. We first observed that SETD2 expression increases during myogenesis. Targeted depletion of SETD2 in undifferentiated (myoblasts) and differentiated (myotubes) muscle cells reduced H3K36me3 levels and induced profound changes in gene expression and slight alterations in alternative splicing, as determined by deep RNA‐sequencing analysis. Enzymes that function in metabolic pathways were upregulated in response to SETD2 depletion. Furthermore, we demonstrated that upregulation of several glycolytic enzymes was associated with an increase in intracellular pyruvate levels in SETD2‐depleted cells, indicating a novel role for SETD2 in metabolic programming during myogenesis. Together, our results provide new insight into the signalling pathways controlled by chromatin‐modifying enzymes and their associated histone modifications during muscle cell differentiation.Keywords
Funding Information
- American Heart Association (19CDA34660248)
- National Institute of General Medical Sciences (R01GM130866, T32GM119999)
- National Science Foundation (DGE‐1650116)
- University of North Carolina at Chapel Hill
This publication has 70 references indexed in Scilit:
- Genome-wide remodeling of the epigenetic landscape during myogenic differentiationProceedings of the National Academy of Sciences, 2011
- KDM5B regulates embryonic stem cell self‐renewal and represses cryptic intragenic transcriptionThe EMBO Journal, 2011
- Abl-interactor-1 (Abi1) has a role in cardiovascular and placental development and is a binding partner of the α4 integrinProceedings of the National Academy of Sciences, 2010
- TNF/p38α/Polycomb Signaling to Pax7 Locus in Satellite Cells Links Inflammation to the Epigenetic Control of Muscle RegenerationCell Stem Cell, 2010
- Genome-wide MyoD Binding in Skeletal Muscle Cells: A Potential for Broad Cellular ReprogrammingDevelopmental Cell, 2010
- UTX mediates demethylation of H3K27me3 at muscle‐specific genes during myogenesisThe EMBO Journal, 2010
- Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodelingProceedings of the National Academy of Sciences, 2010
- Differential chromatin marking of introns and expressed exons by H3K36me3Nature Genetics, 2009
- Pax7 activates myogenic genes by recruitment of a histone methyltransferase complexNature Cell Biology, 2007
- Histone H3 Methylation by Set2 Directs Deacetylation of Coding Regions by Rpd3S to Suppress Spurious Intragenic TranscriptionCell, 2005